The spectrum of anti-GQ1B antibody syndrome: beyond Miller Fisher syndrome and Bickerstaff brainstem encephalitis.
“Anti GQ1b”
“Anti-GQ1b antibody syndrome”
“Anti-ganglioside antibody syndrome”
“Bickerstaff brainstem encephalitis”
“Ganglioside”
“Miller Fisher syndrome”
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
11 Jul 2024
11 Jul 2024
Historique:
received:
18
01
2024
accepted:
03
07
2024
medline:
11
7
2024
pubmed:
11
7
2024
entrez:
10
7
2024
Statut:
aheadofprint
Résumé
Since the initial identification of Miller Fisher syndrome (MFS) and Bickerstaff brainstem encephalitis (BBE),significant milestones have been achieved in understanding these diseases.Discoveries of common serum antibodies (IgG anti-GQ1b), antecedent infections, neurophysiological data, andneuroimaging suggested a shared autoimmune pathogenetic mechanism rather than distinct pathogenesis, leadingto the hypothesis that both diseases are part of a unified syndrome, termed "Fisher-Bickerstaff syndrome". The subsequent identification of atypical anti-GQ1b-positive forms expanded the classification to a broader condition known as "Anti-GQ1b-Antibody syndrome". An exhaustive literature review was conducted, analyzing a substantial body of research spanning from the initialdescriptions of the syndrome's components to recent developments in diagnostic classification and researchperspectives. Anti-GQ1b syndrome encompasses a continuous spectrum of conditions defined by a common serological profilewith varying degrees of peripheral (PNS) and central nervous system (CNS) involvement. MFS and BBE represent theopposite ends of this spectrum, with MFS primarily affecting the PNS and BBE predominantly involving the CNS.Recently identified atypical forms, such as acute ophthalmoparesis, acute ataxic neuropathy withoutophthalmoparesis, Guillain-Barré syndrome (GBS) with ophthalmoparesis, MFS-GBS and BBE-GBS overlap syndromes,have broadened this spectrum. This work aims to provide an extensive, detailed, and updated overview of all aspects of the anti-GQ1b syndromewith the intention of serving as a stepping stone for further shaping thereof. Special attention was given to therecently identified atypical forms, underscoring their significance in redefining the boundaries of the syndrome.
Identifiants
pubmed: 38987510
doi: 10.1007/s10072-024-07686-3
pii: 10.1007/s10072-024-07686-3
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Fondazione Società Italiana di Neurologia.
Références
Yuki N (2009) Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome). J Neuroimmunol 215:1–9. https://doi.org/10.1016/j.jneuroim.2009.05.020
doi: 10.1016/j.jneuroim.2009.05.020
pubmed: 19643503
Wakerley BR, Uncini A, Yuki N et al (2014) Guillain-Barré and Miller Fisher syndromes–new diagnostic classification. Nat Rev Neurol 10:537–544. https://doi.org/10.1038/nrneurol.2014.138
doi: 10.1038/nrneurol.2014.138
pubmed: 25072194
Shahrizaila N, Yuki N (2013) Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 84:576–583. https://doi.org/10.1136/jnnp-2012-302824
doi: 10.1136/jnnp-2012-302824
pubmed: 22984203
Teener JW (2012) Miller Fisher’s syndrome. Semin Neurol 32:512–516. https://doi.org/10.1055/s-0033-1334470
doi: 10.1055/s-0033-1334470
pubmed: 23677659
Guillain G (1938) Synthèse générale De La discussion. J Belge Neurol Psy 38:323–329
Bickerstaff ER, Cloake PCP (1951) Mesencephalitis and rhombencephalitis. Br Med J 2:77–81. https://doi.org/10.1136/bmj.2.4723.77
doi: 10.1136/bmj.2.4723.77
pubmed: 14848512
pmcid: 2069534
Bickerstaff ER (1957) Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis. Br Med J 1:1384–1387. https://doi.org/10.1136/bmj.1.5032.1384
doi: 10.1136/bmj.1.5032.1384
pubmed: 13436795
pmcid: 1973653
Bickerstaff E (1978) Brain stem encephalitis (Bickerstaff’s encephalitis). Handbook of clinical neurolohy, infections of the nervous system. prat II 34:605
Fisher M (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 255:57–65. https://doi.org/10.1056/NEJM195607122550201
doi: 10.1056/NEJM195607122550201
pubmed: 13334797
Noioso CM, Bevilacqua L, Acerra GM et al (2023) Miller Fisher syndrome: an updated narrative review. Front Neurol 14:1250774. https://doi.org/10.3389/fneur.2023.1250774
doi: 10.3389/fneur.2023.1250774
pubmed: 37693761
pmcid: 10484709
Al-Din AN, Anderson M, Bickerstaff ER, Harvey I (1982) Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain 105(Pt 3):481–495. https://doi.org/10.1093/brain/105.3.481
doi: 10.1093/brain/105.3.481
pubmed: 7104664
Anderson M, Al-din AN, Bickerstaff ER, Harvey I (1984) The CNS in Guillain-Barré syndrome. Arch Neurol 41:705. https://doi.org/10.1001/archneur.1984.04050180027009
doi: 10.1001/archneur.1984.04050180027009
pubmed: 6743056
Keane JR, Finstead BA (1982) Upward gaze paralysis as the initial sign of Fisher’s syndrome. Arch Neurol 39:781–782. https://doi.org/10.1001/archneur.1982.00510240043012
doi: 10.1001/archneur.1982.00510240043012
pubmed: 7138323
Ropper AH (1983) The CNS in Guillain-Barré syndrome. Arch Neurol 40:397–398. https://doi.org/10.1001/archneur.1983.04050070027003
doi: 10.1001/archneur.1983.04050070027003
pubmed: 6860172
Ropper AH (1988) Three patients with Fisher’s syndrome and normal MRI. Neurology 38:1630–1631. https://doi.org/10.1212/wnl.38.10.1630
doi: 10.1212/wnl.38.10.1630
pubmed: 3419608
Chiba A, Kusunoki S, Shimizu T, Kanazawa I (1992) Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol 31:677–679. https://doi.org/10.1002/ana.410310619
doi: 10.1002/ana.410310619
pubmed: 1514781
Yuki N, Sato S, Tsuji S et al (1993) An immunologic abnormality common to Bickerstaff’s brain stem encephalitis and Fisher’s syndrome. J Neurol Sci 118:83–87. https://doi.org/10.1016/0022-510x(93)90250-3
doi: 10.1016/0022-510x(93)90250-3
pubmed: 8229054
Mori M, Kuwabara S, Fukutake T et al (2001) Clinical features and prognosis of Miller Fisher syndrome. Neurology 56:1104–1106. https://doi.org/10.1212/wnl.56.8.1104
doi: 10.1212/wnl.56.8.1104
pubmed: 11320188
Lolekha P, Phanthumchinda K (2008) Optic neuritis in a patient with Miller-Fisher syndrome. J Med Assoc Thai 91:1909–1913
pubmed: 19133529
Bae JS, Kim JK, Kim SH, Kim OK (2009) Bilateral internal ophthalmoplegia as an initial sole manifestation of Miller Fisher syndrome. J Clin Neurosci 16:963–964. https://doi.org/10.1016/j.jocn.2008.09.009
doi: 10.1016/j.jocn.2008.09.009
pubmed: 19339185
Akinci G, Oztura I, Hiz-Kurul S (2010) Anti-GQ1b-negative Miller Fisher syndrome presented with one-sided horizontal gaze palsy. Turk J Pediatr 52:317–320
pubmed: 20718193
Yiş U, Bayram E, Topçu Y et al (2013) A case of atypical Miller Fisher syndrome with negative anti-GQ1b immunoglobulin G and importance of H reflex. Turk J Pediatr 55:235–236
pubmed: 24192691
Waung MW, Singer MA (2012) An unusual case of Miller Fisher syndrome presenting with proptosis and chemosis. Muscle Nerve 45:764–766. https://doi.org/10.1002/mus.23285
doi: 10.1002/mus.23285
pubmed: 22499110
pmcid: 3335291
Hara M, Morita A, Ichihara K et al (2012) Miller Fisher syndrome associated with influenza A infection. Intern Med 51:2621–2623. https://doi.org/10.2169/internalmedicine.51.7984
doi: 10.2169/internalmedicine.51.7984
pubmed: 22989838
Kim YK, Kim JS, Jeong S-H et al (2009) Cerebral glucose metabolism in Fisher syndrome. J Neurol Neurosurg Psychiatry 80:512–517. https://doi.org/10.1136/jnnp.2008.154765
doi: 10.1136/jnnp.2008.154765
pubmed: 19066195
Sandler RD, Hoggard N, Hadjivassiliou M (2015) Miller-Fisher syndrome: is the ataxia central or peripheral? Cerebellum Ataxias 2:3. https://doi.org/10.1186/s40673-015-0021-3
doi: 10.1186/s40673-015-0021-3
pubmed: 26331046
pmcid: 4552373
Currie S, Hadjivassiliou M, Wilkinson ID et al (2013) Magnetic resonance spectroscopy of the normal cerebellum: what degree of variability can be expected? Cerebellum 12:205–211. https://doi.org/10.1007/s12311-012-0415-1
doi: 10.1007/s12311-012-0415-1
pubmed: 22987337
Berlit P, Rakicky J (1992) The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol 12:57–63
pubmed: 1532603
Ma Y-M, Liu TKT, Wong V (2010) Guillain-Barre syndrome in southern Chinese children: 32 year experience in Hong Kong. Pediatr Int 52:13–19. https://doi.org/10.1111/j.1442-200X.2009.02951.x
doi: 10.1111/j.1442-200X.2009.02951.x
pubmed: 19702649
Lolekha P, Phanthumchinda K (2009) Miller-Fisher syndrome at King Chulalongkorn Memorial Hospital. J Med Assoc Thai 92:471–477
pubmed: 19374296
Clinical E, Neurology EP (1998) Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. J Neurol Neurosurg Psychiatry 65:218–224. https://doi.org/10.1136/jnnp.65.2.218
Téllez-Zenteno JF, Jacinto-Tinajero JC, Avila-Funes A et al (2001) [Guillain-Barre syndrome. Experience in a third level hospital]. Rev Invest Clin 53:311–314
pubmed: 11599477
Koga M, Kusunoki S, Kaida K et al (2012) Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics. J Neurol Neurosurg Psychiatry 83:1210–1215. https://doi.org/10.1136/jnnp-2012-303060
doi: 10.1136/jnnp-2012-303060
pubmed: 22851608
Odaka M, Yuki N, Yamada M et al (2003) Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 126:2279–2290. https://doi.org/10.1093/brain/awg233
doi: 10.1093/brain/awg233
pubmed: 12847079
San-Juan OD, Martínez-Herrera JF, García JM et al (2009) Miller Fisher syndrome: 10 years’ experience in a third-level center. Eur Neurol 62:149–154. https://doi.org/10.1159/000226599
doi: 10.1159/000226599
pubmed: 19571543
Nagashima T, Koga M, Odaka M et al (2007) Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. Arch Neurol 64:1519–1523. https://doi.org/10.1001/archneur.64.10.1519
doi: 10.1001/archneur.64.10.1519
pubmed: 17923636
Cao Q, Chu H, Fu X et al (2020) Case Report: Acute Bulbar Palsy Plus Syndrome: a Guillain-Barré syndrome variant more prone to be a subtype than overlap of distinct subtypes. Front Neurol 11:566480. https://doi.org/10.3389/fneur.2020.566480
doi: 10.3389/fneur.2020.566480
pubmed: 33329308
pmcid: 7732419
Collier J (1932) Peripheral neuritis. The Morrison Lectures, 1932, delivered before the Royal College of Physicians of Edinburgh, May 1932. Edinb Med J 39:601–618
pubmed: 29639052
pmcid: 5329456
Truong J, Conley J, Ashurst J (2020) Miller-Fisher syndrome: a Case Report and Review of the literature. Clin Pract Cases Emerg Med 4:653–655. https://doi.org/10.5811/cpcem.2020.7.48507
doi: 10.5811/cpcem.2020.7.48507
pubmed: 33217300
pmcid: 7676776
Lyu RK, Tang LM, Cheng SY et al (1997) Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 63:494–500. https://doi.org/10.1136/jnnp.63.4.494
doi: 10.1136/jnnp.63.4.494
pubmed: 9343130
pmcid: 2169759
Kollár K, Liptai Z, Rosdy B, Móser J (2009) [Guillain-Barré syndrome in childhood]. Ideggyogy Sz 62:399–404
pubmed: 20025130
Arányi Z, Kovács T, Sipos I, Bereczki D (2012) Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur J Neurol 19:15–20 e1-3. https://doi.org/10.1111/j.1468-1331.2011.03445.x
doi: 10.1111/j.1468-1331.2011.03445.x
pubmed: 21631649
Smith J, Clarke L, Severn P, Boyce R (2007) Unilateral external ophthalmoplegia in Miller Fisher syndrome: case report. BMC Ophthalmol 7:7. https://doi.org/10.1186/1471-2415-7-7
doi: 10.1186/1471-2415-7-7
pubmed: 17439660
pmcid: 1863413
Wertheim MS, Benzimra JD, Jadresic LP, Ferris JD (2008) Ocular presentation of pediatric Miller-Fisher syndrome. J Pediatr Ophthalmol Strabismus 45:245–246. https://doi.org/10.3928/01913913-20080701-16
doi: 10.3928/01913913-20080701-16
pubmed: 18705624
Stalpers XL, Verhagen WIM, Meulstee J (2009) Isolated bilateral ptosis as the only ophthalmologic sign in the Fisher variant of Guillain-Barré syndrome. J Neuroophthalmol 29:354–355. https://doi.org/10.1097/WNO.0b013e3181b41445
doi: 10.1097/WNO.0b013e3181b41445
pubmed: 19952911
Kinno R, Ichikawa H, Tanigawa H et al (2011) Unilateral abducens nerve Palsy as an early feature of multiple Mononeuropathy Associated with Anti-GQ1b antibody. Case Rep Neurol 3:82–85. https://doi.org/10.1159/000326340
doi: 10.1159/000326340
pubmed: 21490718
pmcid: 3072199
Zhao T, Deng Y, Ding Y et al (2020) Anti-GQ1b antibody syndrome presenting with visual deterioration as the initial symptom: a case report. Med (Baltim) 99:e18805. https://doi.org/10.1097/MD.0000000000018805
doi: 10.1097/MD.0000000000018805
Sim BNH, Joseph JP (2019) Forme fruste anti-GQ1b-negative Miller Fischer syndrome masquerading as posterior circulation stroke. J R Coll Physicians Edinb 49:304–306. https://doi.org/10.4997/JRCPE.2019.411
doi: 10.4997/JRCPE.2019.411
pubmed: 31808458
Koga M (2013) Another CNS phenotype of anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 84:1185. https://doi.org/10.1136/jnnp-2013-305236
doi: 10.1136/jnnp-2013-305236
pubmed: 23704313
Wakerley BR, Soon D, Chan Y-C, Yuki N (2013) Atypical Bickerstaff brainstem encephalitis: ataxic hypersomnolence without ophthalmoplegia. J Neurol Neurosurg Psychiatry 84:1206–1207. https://doi.org/10.1136/jnnp-2013-304993
doi: 10.1136/jnnp-2013-304993
pubmed: 23564757
Ito M, Kuwabara S, Odaka M et al (2008) Bickerstaff’s brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol 255:674–682. https://doi.org/10.1007/s00415-008-0775-0
doi: 10.1007/s00415-008-0775-0
pubmed: 18274803
Kurihara M, Bannai T, Otsuka J et al (2018) Optic neuropathy and decorticate-like posture as presenting symptoms of Bickerstaff’s brainstem encephalitis: a case report and literature review. Clin Neurol Neurosurg 173:159–162. https://doi.org/10.1016/j.clineuro.2018.08.019
doi: 10.1016/j.clineuro.2018.08.019
pubmed: 30144776
Shimozono K, Shimono K, Kusunoki S (2012) [Case of Bickerstaff brainstem encephalitis associated with spindle coma and decorticate posture]. Rinsho Shinkeigaku 52:656–659. https://doi.org/10.5692/clinicalneurol.52.656
doi: 10.5692/clinicalneurol.52.656
pubmed: 22989900
Santoro JD, Lazzareschi DV, Campen CJ, Van Haren KP (2018) Pediatric Bickerstaff brainstem encephalitis: a systematic review of literature and case series. J Neurol 265:141–150. https://doi.org/10.1007/s00415-017-8684-8
doi: 10.1007/s00415-017-8684-8
pubmed: 29177548
Cai L, Hu Z, Liao J et al (2021) Clinical characterization of Anti-GQ1b antibody syndrome in Childhood. Front Pediatr 9:649053. https://doi.org/10.3389/fped.2021.649053
doi: 10.3389/fped.2021.649053
pubmed: 33996691
pmcid: 8116501
Jebaraj AP, Swiston CJ, Vegunta S, Warner JEA (2022) Isolated bilateral Internal Ophthalmoplegia as an atypical initial presentation of anti-GQ1b antibody syndrome. J Neuroophthalmol 42:e389–e390. https://doi.org/10.1097/WNO.0000000000001314
doi: 10.1097/WNO.0000000000001314
pubmed: 34310460
Kim JE, Heo JH, Kim HO et al (2017) Neurological complications during treatment of Middle East Respiratory Syndrome. J Clin Neurol 13:227–233. https://doi.org/10.3988/jcn.2017.13.3.227
doi: 10.3988/jcn.2017.13.3.227
pubmed: 28748673
pmcid: 5532318
Rho YI (2014) Overlapping Guillain-Barré syndrome and Bickerstaff’s brainstem encephalitis associated with Epstein Barr virus. Korean J Pediatr 57:457–460. https://doi.org/10.3345/kjp.2014.57.10.457
doi: 10.3345/kjp.2014.57.10.457
pubmed: 25379047
pmcid: 4219949
Michev A, Musso P, Foiadelli T et al (2019) Bickerstaff Brainstem Encephalitis and overlapping Guillain-Barré syndrome in children: report of two cases and review of the literature. Eur J Paediatr Neurol 23:43–52. https://doi.org/10.1016/j.ejpn.2018.11.008
doi: 10.1016/j.ejpn.2018.11.008
pubmed: 30502045
de Bruyn A, Poesen K, Bossuyt X et al (2019) Clinical spectrum of the anti-GQ1b antibody syndrome: a case series of eight patients. Acta Neurol Belg 119:29–36. https://doi.org/10.1007/s13760-019-01093-8
doi: 10.1007/s13760-019-01093-8
pubmed: 30747336
Richter RB (1962) The ataxic form of polyradiculoneuritis (Landry-Guillain-Barre syndrome). Clinical and pathologic observations. J Neuropathol Exp Neurol 21:171–184
doi: 10.1097/00005072-196204000-00001
pubmed: 14492053
Mihori A, Nakayama M, Ono S, Shimizu N (1998) [Ataxic form of Guillain-Barré syndrome associated with acute hepatitis A–a case report]. Rinsho Shinkeigaku 38:242–245
pubmed: 9711122
Windebank AJ, Blexrud MD, Dyck PJ et al (1990) The syndrome of acute sensory neuropathy: clinical features and electrophysiologic and pathologic changes. Neurology 40:584–591. https://doi.org/10.1212/wnl.40.4.584
doi: 10.1212/wnl.40.4.584
pubmed: 2157173
Ito M, Matsuno K, Sakumoto Y et al (2011) Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum. J Neurol Neurosurg Psychiatry 82:294–299. https://doi.org/10.1136/jnnp.2010.222836
doi: 10.1136/jnnp.2010.222836
pubmed: 21252265
Du FH, Yerevanian A, Shtrahman M (2020) Acute ophthalmoplegia in a patient with anti-GQ1b antibody and chronic facial diplegia. BMJ Case Rep 13:e234319. https://doi.org/10.1136/bcr-2020-234319
doi: 10.1136/bcr-2020-234319
pubmed: 32646933
pmcid: 7351293
Lee S-H, Lim G-H, Kim JS et al (2008) Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody. Neurology 71:426–429. https://doi.org/10.1212/01.wnl.0000324266.95814.74
doi: 10.1212/01.wnl.0000324266.95814.74
pubmed: 18678825
Susuki K, Yuki N, Muramatsu M, Hirata K (2000) Unilateral ophthalmoparesis and limb ataxia associated with anti-GQ1b IgG antibody. J Neurol 247:652–653. https://doi.org/10.1007/s004150070139
doi: 10.1007/s004150070139
pubmed: 11041338
Wakerley BR, Yuki N (2014) Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 85:339–344. https://doi.org/10.1136/jnnp-2013-305397
doi: 10.1136/jnnp-2013-305397
pubmed: 23804237
Ropper AH (1994) Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol 51:671–675. https://doi.org/10.1001/archneur.1994.00540190051014
doi: 10.1001/archneur.1994.00540190051014
pubmed: 8018039
Lee S-U, Kim H-J, Choi J-Y et al (2019) Acute vestibular syndrome associated with anti-GQ1b antibody. Neurology 93:e1085–e1092. https://doi.org/10.1212/WNL.0000000000008107
doi: 10.1212/WNL.0000000000008107
pubmed: 31399495
Gentile S, Messina M, Rainero I et al (2006) Miller Fisher syndrome associated with Burkitt’s lymphoma. Eur J Neurol 13:430. https://doi.org/10.1111/j.1468-1331.2006.01254.x
doi: 10.1111/j.1468-1331.2006.01254.x
pubmed: 16643330
Lo YL (2007) Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve 36:615–627. https://doi.org/10.1002/mus.20835
doi: 10.1002/mus.20835
pubmed: 17657801
Roquer J, Pou Serradell A (1992) [Paraneoplastic Miller-Fisher syndrome?]. Neurologia 7:40
pubmed: 1317716
Csépány T, Boczán J, Magyar MT et al (2004) Miller Fisher syndrome–a presenting clinical manifestation of lung cancer in a previously apparently healthy individual. J Neurol 251:898–900. https://doi.org/10.1007/s00415-004-0465-5
doi: 10.1007/s00415-004-0465-5
pubmed: 15258802
Shin I-SJ, Baer AN, Kwon HJ et al (2006) Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 54:1429–1434. https://doi.org/10.1002/art.21814
doi: 10.1002/art.21814
pubmed: 16645971
Pritchard J, Appleton R, Howard R, Hughes R, a. C (2004) Guillain-Barré syndrome seen in users of isotretinoin. BMJ 328:1537. https://doi.org/10.1136/bmj.328.7455.1537
doi: 10.1136/bmj.328.7455.1537
pubmed: 15217870
pmcid: 437146
Yu EH, Geraldi-Samara D (2020) Pharyngeal-Cervico-Brachial/Miller Fisher Overlap Syndrome with Infliximab exposure. J Clin Neuromuscul Dis 21:157–158. https://doi.org/10.1097/CND.0000000000000274
doi: 10.1097/CND.0000000000000274
pubmed: 32073461
Desai SS, Allen E, Deodhar A (2002) Miller Fisher syndrome in adult onset still’s disease: case report and review of the literature of other neurological manifestations. Rheumatology (Oxford) 41:216–222. https://doi.org/10.1093/rheumatology/41.2.216
doi: 10.1093/rheumatology/41.2.216
pubmed: 11886973
Rubio-Nazabal E, Marey-Lopez J, Torres-Carrete JP et al (2002) Miller-Fisher syndrome and Hodgkin’s disease. J Neurol Neurosurg Psychiatry 73:344. https://doi.org/10.1136/jnnp.73.3.344
doi: 10.1136/jnnp.73.3.344
pubmed: 12185180
pmcid: 1738055
Yuki N (2001) Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infect Dis 1:29–37. https://doi.org/10.1016/S1473-3099(01)00019-6
doi: 10.1016/S1473-3099(01)00019-6
pubmed: 11871407
Martín-Aguilar L, Pascual-Goñi E, Querol L (2019) Autoantibodies in immune-mediated inflammatory neuropathies. Med Clin (Barc) 153:360–367. https://doi.org/10.1016/j.medcli.2019.06.007
doi: 10.1016/j.medcli.2019.06.007
pubmed: 31443948
Kimoto K, Koga M, Odaka M et al (2006) Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies. Neurology 67:1837–1843. https://doi.org/10.1212/01.wnl.0000244468.22377.6b
doi: 10.1212/01.wnl.0000244468.22377.6b
pubmed: 17130419
Koga M, Gilbert M, Li J et al (2005) Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 64:1605–1611. https://doi.org/10.1212/01.WNL.0000160399.08456.7C
doi: 10.1212/01.WNL.0000160399.08456.7C
pubmed: 15883324
Houliston RS, Koga M, Li J et al (2007) A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic. Biochemistry 46:8164–8171. https://doi.org/10.1021/bi700685s
doi: 10.1021/bi700685s
pubmed: 17567050
Gilbert M, Karwaski M-F, Bernatchez S et al (2002) The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem 277:327–337. https://doi.org/10.1074/jbc.M108452200
doi: 10.1074/jbc.M108452200
pubmed: 11689567
Koga M, Gilbert M, Takahashi M et al (2006) Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis. J Infect Dis 193:547–555. https://doi.org/10.1086/499969
doi: 10.1086/499969
pubmed: 16425134
Koga M, Takahashi M, Masuda M et al (2005) Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Neurology 65:1376–1381. https://doi.org/10.1212/01.wnl.0000176914.70893.14
doi: 10.1212/01.wnl.0000176914.70893.14
pubmed: 16162859
Susuki K, Baba H, Tohyama K et al (2007) Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers. Glia 55:746–757. https://doi.org/10.1002/glia.20503
doi: 10.1002/glia.20503
pubmed: 17352383
Uncini A (2023) Autoimmune nodo-paranodopathies 10 years later: clinical features, pathophysiology and treatment. J Peripher Nerv Syst 28(Suppl 3):S23–S35. https://doi.org/10.1111/jns.12569
doi: 10.1111/jns.12569
pubmed: 37272673
Chiba A, Kusunoki S, Obata H et al (1997) Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res 745:32–36. https://doi.org/10.1016/s0006-8993(96)01123-7
doi: 10.1016/s0006-8993(96)01123-7
pubmed: 9037391
Koga M, Yoshino H, Morimatsu M, Yuki N (2002) Anti-GT1a IgG in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 72:767–771. https://doi.org/10.1136/jnnp.72.6.767
doi: 10.1136/jnnp.72.6.767
pubmed: 12023422
pmcid: 1737908
Kaymakamzade B, Selcuk F, Koysuren A et al (2013) Pupillary involvement in Miller Fisher Syndrome. Neuroophthalmology 37:111–115. https://doi.org/10.3109/01658107.2013.792356
doi: 10.3109/01658107.2013.792356
pubmed: 28163765
pmcid: 5289578
Lee S-U, Kim H-J, Choi J-Y, Kim J-S (2019) Anti-ganglioside antibody-associated acute unilateral peripheral vestibulopathy. J Neurol 266:250–252. https://doi.org/10.1007/s00415-018-9109-z
doi: 10.1007/s00415-018-9109-z
pubmed: 30421339
Jung I, Kim H-J, Kim J-S (2017) Fluctuating ataxia and nystagmus in association with anti-GQ1b antibody in HIV infection. J Neurol Sci 382:123–125. https://doi.org/10.1016/j.jns.2017.09.044
doi: 10.1016/j.jns.2017.09.044
pubmed: 29111004
Zaro-Weber O, Galldiks N, Dohmen C et al (2008) Ocular flutter, generalized myoclonus, and trunk ataxia associated with anti-GQ1b antibodies. Arch Neurol 65:659–661. https://doi.org/10.1001/archneur.65.5.659
doi: 10.1001/archneur.65.5.659
pubmed: 18474744
Saito K, Shimizu F, Koga M et al (2013) Blood-brain barrier destruction determines Fisher/Bickerstaff clinical phenotypes: an in vitro study. J Neurol Neurosurg Psychiatry 84:756–765. https://doi.org/10.1136/jnnp-2012-304306
doi: 10.1136/jnnp-2012-304306
pubmed: 23584494
Faraci FM, Choi J, Baumbach GL et al (1989) Microcirculation of the area postrema. Permeability and vascular responses. Circ Res 65:417–425. https://doi.org/10.1161/01.res.65.2.417
doi: 10.1161/01.res.65.2.417
pubmed: 2752549
Van Breemen VL, Clemente CD (1955) Silver deposition in the central nervous system and the hematoencephalic barrier studied with the electron microscope. J Biophys Biochem Cytol 1:161–166. https://doi.org/10.1083/jcb.1.2.161
doi: 10.1083/jcb.1.2.161
pubmed: 14381438
pmcid: 2223766
Odaka M, Yuki N, Tatsumoto M et al (2004) Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1 antibodies. J Neurol 251:24–29. https://doi.org/10.1007/s00415-004-0259-9
doi: 10.1007/s00415-004-0259-9
pubmed: 14999485
Yuki N, Susuki K, Hirata K (2000) Ataxic form of Guillain-Barré syndrome associated with anti-GD1b IgG antibody. J Neurol Neurosurg Psychiatry 69:136–137. https://doi.org/10.1136/jnnp.69.1.136
doi: 10.1136/jnnp.69.1.136
pubmed: 10864627
pmcid: 1736994
Mao L, Jin H, Wang M et al (2020) Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 77:683–690. https://doi.org/10.1001/jamaneurol.2020.1127
doi: 10.1001/jamaneurol.2020.1127
pubmed: 32275288
Maury A, Lyoubi A, Peiffer-Smadja N et al (2021) Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: a narrative review for clinicians. Rev Neurol (Paris) 177:51–64. https://doi.org/10.1016/j.neurol.2020.10.001
doi: 10.1016/j.neurol.2020.10.001
pubmed: 33446327
Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E et al (2020) Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology 95:e1060–e1070. https://doi.org/10.1212/WNL.0000000000009937
doi: 10.1212/WNL.0000000000009937
pubmed: 32482845
pmcid: 7668545
Aladawi M, Elfil M, Abu-Esheh B et al (2022) Guillain Barre Syndrome as a complication of COVID-19: a systematic review. Can J Neurol Sci 49:38–48. https://doi.org/10.1017/cjn.2021.102
doi: 10.1017/cjn.2021.102
pubmed: 33949300
Dang YL, Bryson A (2021) Miller-Fisher Syndrome and Guillain-Barre syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Rep 14:e246701. https://doi.org/10.1136/bcr-2021-246701
doi: 10.1136/bcr-2021-246701
pubmed: 34848426
pmcid: 8634230
Nishiguchi Y, Matsuyama H, Maeda K et al (2021) Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC Neurol 21:452. https://doi.org/10.1186/s12883-021-02489-x
doi: 10.1186/s12883-021-02489-x
pubmed: 34789193
pmcid: 8598937
Neophytou P, Artemiadis A, Hadjigeorgiou GM, Zis P (2023) Miller Fischer syndrome after COVID-19 infection and vaccine: a systematic review. Acta Neurol Belg. https://doi.org/10.1007/s13760-023-02336-5
doi: 10.1007/s13760-023-02336-5
pubmed: 37468803
pmcid: 10505097
Monte G, Pro S, Ursitti F et al (2022) Case report: a pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: looking for the culprit. Front Immunol 13:987968. https://doi.org/10.3389/fimmu.2022.987968
doi: 10.3389/fimmu.2022.987968
pubmed: 36032138
pmcid: 9411636
Finsterer J, Matovu D (2022) Do not miss Bickerstaff encephalitis as a complication of SARS-CoV-2 vaccines. Radiol Case Rep 17:2824–2825. https://doi.org/10.1016/j.radcr.2022.05.044
doi: 10.1016/j.radcr.2022.05.044
pubmed: 35694633
pmcid: 9174925
Nishimoto Y, Odaka M, Hirata K, Yuki N (2004) Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol 148:200–205. https://doi.org/10.1016/j.jneuroim.2003.11.017
doi: 10.1016/j.jneuroim.2003.11.017
pubmed: 14975602
Kusunoki S, Shimizu J, Chiba A et al (1996) Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 39:424–431. https://doi.org/10.1002/ana.410390404
doi: 10.1002/ana.410390404
pubmed: 8619520
Liu J-X, Willison HJ, Pedrosa-Domellöf F (2009) Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. Invest Ophthalmol Vis Sci 50:3226–3232. https://doi.org/10.1167/iovs.08-3333
doi: 10.1167/iovs.08-3333
pubmed: 19255160
Kusunoki S, Chiba A, Kanazawa I (1999) Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve 22:1071–1074. https://doi.org/10.1002/(sici)1097-4598(199908)22:8%3C1071::aid-mus10%3E3.0.co;2-0
doi: 10.1002/(sici)1097-4598(199908)22:8<1071::aid-mus10>3.0.co;2-0
pubmed: 10417789
Vajn K, Viljetić B, Degmečić IV et al (2013) Differential distribution of major brain gangliosides in the adult mouse central nervous system. PLoS ONE 8:e75720. https://doi.org/10.1371/journal.pone.0075720
doi: 10.1371/journal.pone.0075720
pubmed: 24098718
pmcid: 3787110
Chiba A, Kusunoki S, Obata H et al (1993) Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 43:1911–1917. https://doi.org/10.1212/wnl.43.10.1911
doi: 10.1212/wnl.43.10.1911
pubmed: 8413947
Susuki K, Yuki N, Hirata K (2001) Fine specificity of anti-GQ1b IgG and clinical features. J Neurol Sci 185:5–9. https://doi.org/10.1016/s0022-510x(01)00464-6
doi: 10.1016/s0022-510x(01)00464-6
pubmed: 11266684
Fukami Y, Wong AHY, Funakoshi K et al (2016) Anti-GQ1b antibody syndrome: anti-ganglioside complex reactivity determines clinical spectrum. Eur J Neurol 23:320–326. https://doi.org/10.1111/ene.12769
doi: 10.1111/ene.12769
pubmed: 26176883
Kashihara K, Shiro Y, Koga M, Yuki N (1998) IgG anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 65:799. https://doi.org/10.1136/jnnp.65.5.799
doi: 10.1136/jnnp.65.5.799
pubmed: 9810965
pmcid: 2170341
Taphoorn MJ, Uitdehaag BM, Lanting P (1991) A brain-stem lesion in the Miller Fisher syndrome demonstrated by CT and MRI. J Neurol 238:243. https://doi.org/10.1007/BF00314791
doi: 10.1007/BF00314791
pubmed: 1895158
Giroud M, Mousson C, Chalopin JM et al (1990) Miller-Fisher syndrome and pontine abnormalities on MRI: a case report. J Neurol 237:489–490. https://doi.org/10.1007/BF00314769
doi: 10.1007/BF00314769
pubmed: 1963636
Garcia-Rivera CA, Rozen TD, Zhou D et al (2001) Miller Fisher syndrome: MRI findings. Neurology 57:1755. https://doi.org/10.1212/wnl.57.10.1755
doi: 10.1212/wnl.57.10.1755
pubmed: 11723258
Romano N, Federici M, Castaldi A (2021) Imaging presentation of Bickerstaff Brainstem Encephalitis. Neurohospitalist 11:370–372. https://doi.org/10.1177/1941874421993671
doi: 10.1177/1941874421993671
pubmed: 34567402
pmcid: 8442150
Hiew FL, Ramlan R, Viswanathan S, Puvanarajah S (2017) Guillain-Barré syndrome, variants & forms fruste: reclassification with new criteria. Clin Neurol Neurosurg 158:114–118. https://doi.org/10.1016/j.clineuro.2017.05.006
doi: 10.1016/j.clineuro.2017.05.006
pubmed: 28514704
Wakerley BR, Kokubun N, Funakoshi K et al (2016) Clinical classification of 103 Japanese patients with Guillain-Barré syndrome. J Neurol Sci 369:43–47. https://doi.org/10.1016/j.jns.2016.08.002
doi: 10.1016/j.jns.2016.08.002
pubmed: 27653863
Sauron B, Bouche P, Cathala HP et al (1984) Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology 34:953–956. https://doi.org/10.1212/wnl.34.7.953
doi: 10.1212/wnl.34.7.953
pubmed: 6539872
Fross RD, Daube JR (1987) Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 37:1493–1498. https://doi.org/10.1212/wnl.37.9.1493
doi: 10.1212/wnl.37.9.1493
pubmed: 2819783
Jamal GA, Ballantyne JP (1988) The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome). A serial multimodal neurophysiological study. Brain 111(Pt 1):95–114. https://doi.org/10.1093/brain/111.1.95
doi: 10.1093/brain/111.1.95
pubmed: 2835120
Dachy B, Deltenre P, Deconinck N, Dan B (2010) The H reflex as a diagnostic tool for Miller Fisher syndrome in pediatric patients. J Clin Neurosci 17:410–411. https://doi.org/10.1016/j.jocn.2009.06.014
doi: 10.1016/j.jocn.2009.06.014
pubmed: 20071180
Ogawara K, Kuwabara S, Yuki N (2002) Fisher syndrome or Bickerstaff brainstem encephalitis? Anti-GQ1b IgG antibody syndrome involving both the peripheral and central nervous systems. Muscle Nerve 26:845–849. https://doi.org/10.1002/mus.10246
doi: 10.1002/mus.10246
pubmed: 12451613
Arai M, Susuki K, Koga M (2003) Axonal pharyngeal-cervical-brachial variant of Guillain–Barré syndrome without Anti-GT1a IgG antibody. Muscle Nerve 28:246–250. https://doi.org/10.1002/mus.10424
doi: 10.1002/mus.10424
pubmed: 12872333
Kim JK, Kim B-J, Shin HY et al (2016) Acute bulbar palsy as a variant of Guillain-Barré syndrome. Neurology 86:742–747. https://doi.org/10.1212/WNL.0000000000002256
doi: 10.1212/WNL.0000000000002256
pubmed: 26718574
Yuki N, Uncini A (2014) Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism. Muscle Nerve 49:629–635. https://doi.org/10.1002/mus.24192
doi: 10.1002/mus.24192
pubmed: 24477718
Kuwabara S, Asahina M, Nakajima M et al (1999) Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis. Ann Neurol 45:533–536. https://doi.org/10.1002/1531-8249(199904)45:4%3C533::aid-ana19%3E3.0.co;2-h
doi: 10.1002/1531-8249(199904)45:4<533::aid-ana19>3.0.co;2-h
pubmed: 10211482
Bergin PS, Bronstein AM, Murray NM et al (1995) Body sway and vibration perception thresholds in normal aging and in patients with polyneuropathy. J Neurol Neurosurg Psychiatry 58:335–340. https://doi.org/10.1136/jnnp.58.3.335
doi: 10.1136/jnnp.58.3.335
pubmed: 7897416
pmcid: 1073371
Kurihara T, Igarashi Y, Kobai K et al (2020) Diagnosis and prediction of prognosis for Bickerstaff’s brainstem encephalitis using auditory brainstem response: a case report. Acute Med Surg 7:e517. https://doi.org/10.1002/ams2.517
doi: 10.1002/ams2.517
pubmed: 32685172
pmcid: 7266809
Jacobs BC, O’Hanlon GM, Bullens RWM et al (2003) Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain 126:2220–2234. https://doi.org/10.1093/brain/awg235
doi: 10.1093/brain/awg235
pubmed: 12876146
Mori M, Kuwabara S, Fukutake T, Hattori T (2007) Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology 68:1144–1146. https://doi.org/10.1212/01.wnl.0000258673.31824.61
doi: 10.1212/01.wnl.0000258673.31824.61
pubmed: 17404197
Hughes RAC, Swan AV, Raphaël J-C et al (2007) Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 130:2245–2257. https://doi.org/10.1093/brain/awm004
doi: 10.1093/brain/awm004
pubmed: 17337484
Overell JR, Hsieh ST, Odaka M et al (2007) Treatment for Fisher syndrome, Bickerstaff’s brainstem encephalitis and related disorders. Cochrane Database Syst Rev 2007:CD004761. https://doi.org/10.1002/14651858.CD004761.pub2
doi: 10.1002/14651858.CD004761.pub2
pubmed: 17253522
pmcid: 8407391
Kaida K, Kusunoki S, Kanzaki M et al (2004) Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome. Neurology 62:821–824. https://doi.org/10.1212/01.wnl.0000113718.27729.43
doi: 10.1212/01.wnl.0000113718.27729.43
pubmed: 15007143
Hardy TA, Barnett MH, Mohamed A et al (2012) Severe Bickerstaff’s encephalitis treated with Rituximab: serum and CSF GQ1b antibodies. J Neuroimmunol 251:107–109. https://doi.org/10.1016/j.jneuroim.2012.07.008
doi: 10.1016/j.jneuroim.2012.07.008
pubmed: 22868227
Halstead SK, Zitman FMP, Humphreys PD et al (2008) Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131:1197–1208. https://doi.org/10.1093/brain/awm316
doi: 10.1093/brain/awm316
pubmed: 18184663
Fletcher DD, Lawn ND, Wolter TD, Wijdicks EFM (2000) Long-term outcome in patients with Guillain–Barré syndrome requiring mechanical ventilation. Neurology 54:2311–2315. https://doi.org/10.1212/WNL.54.12.2311
doi: 10.1212/WNL.54.12.2311
pubmed: 10881259
Heckmann JG, Dütsch M (2012) Recurrent Miller Fisher syndrome: clinical and laboratory features. Eur J Neurol 19:944–954. https://doi.org/10.1111/j.1468-1331.2011.03584.x
doi: 10.1111/j.1468-1331.2011.03584.x
pubmed: 22117529
Vermeersch G, Boschi A, Deggouj N et al (2011) Recurrent Miller Fisher syndrome with vestibular involvement. Eur Neurol 66:210–214. https://doi.org/10.1159/000331486
doi: 10.1159/000331486
pubmed: 21934313
Toru S, Ohara M, Hane Y et al (2012) Successful steroid treatment for recurrent Miller Fisher syndrome. Muscle Nerve 45:763–764. https://doi.org/10.1002/mus.23257
doi: 10.1002/mus.23257
pubmed: 22499109
Grosso S, Verrotti A, Tei M et al (2014) Recurrent Miller Fisher syndrome in children. Pediatr Neurol 50:269–271. https://doi.org/10.1016/j.pediatrneurol.2013.10.016
doi: 10.1016/j.pediatrneurol.2013.10.016
pubmed: 24321544
Dong H, Liu Z, Tang Y et al (2011) Recurrent Fisher-Bickerstaff syndrome: report of a Chinese case. Chin Med J (Engl) 124:2786–2788
pubmed: 22040444
Sharma V, Chan YC, Ong null et al (2006) Bickerstaff’s brainstem encephalitis: can it recur? J Clin Neurosci 13:277–279. https://doi.org/10.1016/j.jocn.2005.01.011
doi: 10.1016/j.jocn.2005.01.011
pubmed: 16442797
Chamsi Basha A, Kolko N, Santoro JD, Alomani H (2020) A probable case of recurrent Bickerstaff Brainstem Encephalitis with Fulminant Course in a Pediatric patient. Neurologist 25:14–16. https://doi.org/10.1097/NRL.0000000000000255
doi: 10.1097/NRL.0000000000000255
pubmed: 31876654
Ishii J, Yuki N, Kawamoto M et al (2016) Recurrent Guillain-Barré syndrome, Miller Fisher syndrome and Bickerstaff brainstem encephalitis. J Neurol Sci 364:59–64. https://doi.org/10.1016/j.jns.2016.03.008
doi: 10.1016/j.jns.2016.03.008
pubmed: 27084218
Chida K, Nomura H, Konno H et al (1999) Recurrent Miller Fisher syndrome: clinical and laboratory features and HLA antigens. J Neurol Sci 165:139–143. https://doi.org/10.1016/s0022-510x(99)00095-7
doi: 10.1016/s0022-510x(99)00095-7
pubmed: 10450799